Share

'Too many patients' struggling to pay cholesterol drug: Amgen CEO on price cut

Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
01:11
Mon, Jan 7 20196:51 PM EST